Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B2 | P19099 | 1/20 | 0.41 |
| ▸ | ACACB | O00763 | 5/20 | 0.41 |
| ▸ | SCD5 | Q86SK9 | 1/20 | 0.40 |
| ▸ | RET | P07949 | 8/20 | 0.39 |
| ▸ | SPR | P35270 | 3/20 | 0.38 |
| ▸ | USP2 | O75604 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.36 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL627422 | 0.93 | RET (0.42) | CYP11B2ACACBSCD5RETUSP2 | |
| SCHEMBL628407 | 0.93 | CYP11B2 (0.44) | CYP11B2ACACBSCD5RETCYP3A4 | |
| SCHEMBL627265 | 0.87 | CKS1B (0.41) | — | |
| SCHEMBL625492 | 0.81 | NAMPT (0.39) | ACACB | |
| SCHEMBL627207 | 0.80 | OPRM1 (0.39) | SPR | |
| SCHEMBL627266 | 0.80 | CYP11B2 (0.41) | CYP11B2ACACBSCD5RETSPR | |
| SCHEMBL627513 | 0.77 | OPRM1 (0.37) | — | |
| SCHEMBL627020 | 0.77 | RET (0.40) | RETHDAC1HDAC2 | |
| SCHEMBL627341 | 0.76 | NAMPT (0.47) | — | |
| SCHEMBL627421 | 0.75 | RET (0.44) | CYP11B2ACACBRETUSP2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2012020215-A1 | AMINO- IMIDAZOLOTHIADIAZOLES FOR USE AS PROTEIN OR LIPID KINASE INHIBITORS | CENTRO NACIONAL DE INVESTIGACIONES ONCOLÓGICAS (CNIO) (ES) | 2012-02-16 | — | — | WO | disclosed |